VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / April 4, 2025 / Lobe Sciences Ltd. ("Lobe" or the "Company") (CSE:LOBE)(OTCQB:LOBEF)(FWB:LOBE.F), a commercial s
Lobe Sciences, Ltd. ("Lobe Sciences" or the "Company") (CSE: LOBE), (OTCQB: LOBEF) and Alera Pharma, Inc. (”Alera” or ”Alera Pharma”), biopharmaceutica
U.S. Patent Office issues notice of allowance for a second patent for Conjugated Psilocin™ Once issued, this patent will provide additional coverage for psilocin …
U.S. Patent Office issues patent number 12,102,616 Patent covers the compositions of matter, methods of use and methods of production for Conjugated Psilocin™ A…
Annual General Meeting elects new Board of Directors: Dr. Frederick D. Sancilio, Dr. Harry Jacobson and Mr. Wesley Ramjeet Board announces resignations of CEO Phi…
VANCOUVER, British Columbia — Lobe Sciences Ltd. (“Lobe” or the “Company”) (OTCQB: LOBEF) (CSE: LOBE), a biopharmaceutical company focused on developing…
Point Roberts, WA and Delta, BC - April 9, 2021 (Investorideas.com Newswire) Investorideas.com, a global news source and leading retail investor and trader reso...